Mark K. Dodson
( out of 48 reviews )

Mark K. Dodson, MD

Languages spoken: English

Clinical Locations

Primary Location

Obstetrics & Gynecology Avenues Clinic

University of Utah Health Care Avenues Clinic
370 Ninth Avenue
Salt Lake City , UT 84103
801-587-2809
Get Directions

Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

Specialties

Patient Rating

Patients consistently praise Dr. Dodson for his clinical skill, clear explanations, use of diagrams, and the time he spends addressing concerns, with many describing him as kind, empathetic, and a confident surgeon. Several comments highlight that his team also provides compassionate, competent care that made patients feel safe. A minority of reviews report feeling rushed or interrupted, concerns about bedside manner being occasionally jaded, and frustrations with scheduling, wait times, or staff follow-up. Some patients also prefer in-person visits over telehealth for reassurance during recovery.

Generated via Patient Reviews

5.0 /5
( out of 48 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Nov 12, 2025
HUNTSMAN CANCER CENTER

Dr. Dodson saved my life, and has always taken time for me at my follow up appointments. He listens and remembers what I have issues with. I appreciate his attentiveness.

Apr 10, 2025
HUNTSMAN CANCER CENTER

Dr. Mark K. Dodson found uterine cancer just in time to save my life. I feel like he considers life a precious gift. The doctor is an intelligent, kind, and very empathetic person. He takes time to explain each of the procedures that will be performed and asks if you have any concerns about your health. This last time I visited him, he not only addressed my concerns about my cancer that I had in [DATE REMOVED], but he also took the time to ask me how I was feeling after a car accident I had in [DATE REMOVED]. An incredible human being. He's my favorite doctor. Thank you for your concern!!! [TRANSLATED]

Apr 10, 2025
HUNTSMAN CANCER CENTER

Dr. Dodson is exceptional in treating his patients as people, explaining everything clearly regarding the medical procedures, and conditions one is facing. Beyond fortunate to be under his care.

Jan 16, 2025
HUNTSMAN CANCER CENTER

The best of the best!

Nov 13, 2024
HUNTSMAN CANCER CENTER

He tells you the truth and is up front about everything. I appreciate that in a doctor.

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Mark K. Dodson, M.D., is a gynecological oncologist at the University of Utah. As a Gynecologic Oncology investigator, he treats gynecologic cancers and pre-cancers. His clinical research focuses on minimally invasive surgery and novel treatments of gynecologic malignancies and his expertise is in radical abdominal pelvic surgery with particular emphasis on minimally invasive surgery. His basic science research interests include drug delivery systems, particularly for treating ovarian cancer. Dr. Dodson received his medical degree from the Quillen School of Medicine at East Tennessee State University. He joined the University of Utah after completing his fellowship in gynecologic oncology at the Mayo Clinic in Rochester, Minnesota. He is the co-founder of the Susan Sandoval Run for Ovarian Cancer, an annual event sponsored by the University of Utah Department of Obstetrics and Gynecology, from which all proceeds are used to meet the goals of the Ovarian Cancer Education, Awareness and Research Fund. Dr. Dodson is also the founder of the Gynecologic Oncology Outreach Program at the Sletten Cancer Institute in Great Falls, MT, where he sees patients twice a month.

Board Certification and Academic Information

Academic Departments Obstetrics & Gynecology -Professor (Clinical)
Academic Divisions Gynecological Oncology

Education history

Undergraduate Biology - Middle Tennessee State University B.S.
Professional Medical Medicine - East Tennessee State University M.D.
Internship OB/GYN - Charity Hospital of Louisiana Intern
Residency OB/GYN - University of Mississippi Resident
Fellowship Gynecolgic Oncology - Mayo Clinic Fellow

Selected Publications

Journal Article

  1. Baker WD, Soisson AP, Dodson M (2013). Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report. The journal of obstetrics and gynaecology research, 39(4), 876-78.
  2. Dorais J, Dodson MK, Calvert J, Mize B, Travarelli J, Jasperson K, Peterson CM, Soisson A (2011). Fertility-sparing management of endometrial adenocarcinoma. Obstetrical & gynecological survey, 66(7), 443-51.
  3. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney D (2009). Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. American journal of clinical oncology, 32(4), 411-6.
  4. Macdonald OK, Sause WT, Lee RJ, Lee CM, Dodson MK, Zempolich K, Gaffney D (2006). Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecologic oncology, 103(2), 661-6.
  5. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich K (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clinical cancer research, 12(1), 250-6.
  6. Macdonald OK, Sause WT, Lee RJ, Dodson MK, Zempolich K, Gaffney D (2005). Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium?. Gynecologic oncology, 99(3), 730-5.
  7. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau (2004). Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clinical cancer research, 10(8), 2681-6.
  8. Orr JW Jr, Montz FJ, Barter J, Schaitzberg SD, Delmore JE, Dodson MK, Gallup D, Yeh KA, Elias E (2003). Continuous abdominal fascial closure: a randomized controlled trial of poly(L-lactide/glycolide). Gynecologic oncology, 90(2), 342-7.
  9. Sharp HT, Dodson MK, Draper ML, Watts DA, Doucette RC, Hurd W (2002). Complications associated with optical-access laparoscopic trocars. Obstetrics and gynecology, 99(4), 553-5.

Abstract

  1. Cho S, Soisson AP, Dodson MK , Gaffney DK, Peterson CM, Janat-Amsbury (2011). Anticancer drug delivery utilizing a mucoadhesive hybrid gel for loco-regional gynecologic applications.
  2. Janat-Amsbury M, Kablitz C, Gupta K, Soisson A, Peterson C, Dodson M (2010). Nanoparticle-loaded mucoadhesviehydrogels for the local treatment of cervical cancer.
  3. Dodson MK, Belnap T, Sause W, Soisson (2010). Inappropriate use of human papillomavirus testing aat time of routine Pap.
  4. Soisson A, Dodson MK, Webb J, Moore H, Hunn J, Donaldson C, Belnap T, Wendt L, Alleman K, Sause (2010). Surgical outcomes in women with endometrial carcinoma undergoing hysterectomy by a gynecoloist at a community hospital.
  5. Moore H, Soisson A, Dodson MK, Rowe K, Cannon-Albright (2010). Familial clustering of endometrial cancer in a well defined population.
  6. Pittman JH, Soisson AP, Dodson MK, Hunn JR, Moore H, Webb J, Soisson E, Belnap T, Alleman K, Sause W, Janat-Amsbury (2010). Accuracy of surgical assessment of myometrial invasion in women with endometrial cancer.
  7. Hunn J, Soisson AP, Dodson M (2009). The immunostimulant keyhole limpet hemocyanin inhibits cervical cancer cell growth in-vitro via apoptosis and DNA double strand breaks.
  8. Soisson AP, Dodson M (2008). Differences in surgical procedures between general gynecologists and gynecologic oncologists for women with endometrial cancer.
  9. Soisson EE, Soisson AP, Kulgren R, Dodson MK, Zempolich K, Sause W, Gaffney D, Rowe K, Alleman K, Pinto (2007). insufficient surgical staging by general gynecologists compared to gynecologic oncologists for women with endometrial cancer.
  10. Soisson E, Soisson AP, Zempolich K, Dodson MK, Sause W, Gaffney D, Horvath (2006). An analysis of differences in care for women with endometrial adenocarcinoma: Surgical care by general gynecologists in the community compared to gynecologic oncologists at tertiary medical centers: Preliminary information.